Return on average equity - 5 year average | - |
Net Income/employee - trailing 12 month | 1,391.30 |
Revenue/employee - most recent fiscal year | - |
Return on investment - most recent fiscal year | -13.68 |
Return on average assets - most recent fiscal year | -5.92 |
Receivables turnover - most recent fiscal year | 4.53 |
Return on investment - trailing 12 month | 0.07 |
Return on average assets - trailing 12 month | 0.03 |
Inventory turnover - most recent fiscal year | 3.22 |
Inventory turnover - trailing 12 month | 3.12 |
Revenue/employee - trailing 12 month | 28,77,534.00 |
Return on average assets - 5 year average | -10.28 |
Net Income/employee - most recent fiscal year | - |
Return on average equity - trailing 12 month | - |
Receivables turnover - trailing 12 month | 2.95 |
Asset turnover - most recent fiscal year | 0.68 |
Asset turnover - trailing 12 month | 0.67 |
Return on average equity - most recent fiscal year | - |
Return on investment - 5 year average | -23.90 |
Oxygenta Pharmaceutical Dividend Oxygenta Pharmaceutical Bonus Oxygenta Pharmaceutical News Oxygenta Pharmaceutical AGM Oxygenta Pharmaceutical Rights Oxygenta Pharmaceutical Splits Oxygenta Pharmaceutical Board Meetings Oxygenta Pharmaceutical Shareholdings Oxygenta Pharmaceutical Profit Loss Oxygenta Pharmaceutical Balance Sheet Oxygenta Pharmaceutical Cashflow Oxygenta Pharmaceutical Q1 Results Oxygenta Pharmaceutical Q2 Results Oxygenta Pharmaceutical Q3 Results Oxygenta Pharmaceutical Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks